Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-10-027588
Filing Date
2010-03-24
Accepted
2010-03-24 13:34:49
Documents
7
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c97814e10vk.htm 10-K 662817
2 LIST OF SUBSIDIARIES c97814exv21w1.htm EX-21.1 25863
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM c97814exv23w1.htm EX-23.1 1926
4 CEO CERTIFICATION PURSUANT TO SECTION 302 c97814exv31w1.htm EX-31.1 8091
5 CFO CERTIFICATION PURSUANT TO SECTION 302 c97814exv31w2.htm EX-31.2 8022
6 CEO CERTIFICATION PURSUANT TO SECTION 906 c97814exv32w1.htm EX-32.1 3307
7 CFO CERTIFICATION PURSUANT TO SECTION 906 c97814exv32w2.htm EX-32.2 3206
  Complete submission text file 0000950123-10-027588.txt   714666
Mailing Address 520 VIRGINIA DRIVE FORT WASHINGTON PA 19034
Business Address 520 VIRGINIA DRIVE FORT WASHINGTON PA 19034 215-540-0700
RESEARCH PHARMACEUTICAL SERVICES, INC. (Filer) CIK: 0001420070 (see all company filings)

EIN.: 204322769 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52981 | Film No.: 10701294
SIC: 8731 Services-Commercial Physical & Biological Research